Clinical trial

Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer

NCT04486495

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2020-07-16

PhaseN/A

Study timeline

Study start (actual)2020-07-16Date precision: day

Registry last updated2022-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Neoadjuvant Therapyunresolved

Lymph Node Metastasesunresolved

Interventions

Sponsors & collaborators

Maastricht University Medical Centerlead sponsor

Erasmus Medical Centercollaborator

The Netherlands Cancer Institutecollaborator

Mapped research locations

RotterdamNetherlands4 AmsterdamNetherlands1 GroningenNetherlands1 NijmegenNetherlands1 MaastrichtNetherlands1 UtrechtNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04486495 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.